Welcome to our dedicated page for Verano Hldgs news (Ticker: VRNO), a resource for investors and traders seeking the latest updates and insights on Verano Hldgs stock.
Verano Holdings Corp. (VRNO) is a vertically integrated, multi-state cannabis company whose activities generate frequent news across operations, finance, regulation and product development. As one of the U.S. cannabis industry’s notable operators by historical revenue, geographic scope and brand performance, Verano’s announcements often reflect broader developments in regulated cannabis markets.
News about Verano commonly covers its expanding retail and cultivation footprint, including new Zen Leaf™ and MÜV™ dispensary openings and updates on its 13-state operations. Articles may highlight additional dispensary locations in medical markets such as West Virginia, or progress on licenses like the conditional Dispensing Organization License in Texas, which, subject to final approval, would permit cultivation, processing and dispensing of medical cannabis in that state.
Investors and industry followers can also expect coverage of Verano’s branded product portfolio. This includes launches and expansions of brands such as Swift Lifts, a pre-roll brand positioned around quality and convenience, as well as updates on products sold under the Verano™, (the) Essence™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™ labels.
Financial and regulatory news is another key theme, including disclosures on credit facilities and capital structure. For example, Verano has reported amendments to its revolving credit facility that increased borrowing capacity and extended maturity, as well as commentary on federal policy shifts like cannabis rescheduling initiatives. For readers tracking VRNO, this news feed offers a centralized view of the company’s operational milestones, financing developments and regulatory context over time.
Verano (Cboe CA: VRNO / OTCQX: VRNO) amended its revolving credit facility, increasing the commitment from $75,000,000 to $100,000,000 and extending the maturity from September 29, 2028 to February 28, 2029. No additional collateral was pledged; the facility remains secured by certain owned real estate. To date $50,000,000 has been drawn, leaving $50,000,000 available subject to conditions. Borrowings accrue interest at SOFR + 6% (4% SOFR floor), permit repayment in $2,500,000 increments with an interest-only make-whole if repaid before six months, and allow proportionate real estate release while outstanding balance remains ≤80% of appraised collateral value.
Verano (Cboe CA: VRNO / OTCQX: VRNO) launched Swift Lifts as a standalone pre-roll brand on January 14, 2026. The rollout starts at Verano’s Zen Leaf dispensaries and third-party partners in five core markets: Arizona, Illinois, Maryland, New Jersey and Nevada, with plans to scale to Connecticut, Virginia and MÜV dispensaries in Florida. Swift Lifts offers Short Lifts (10 x 0.35g), Swift Lifts (5 x 0.5g) and Long Lifts (1.0g), with later expansion into infused and coated SKUs. Pre-rolls grew over 22% in 2025 and represented > 13% of 2025 cannabis sales. Verano operates in 13 U.S. states with 15 production facilities and ~1.1 million sq ft cultivation capacity.
Verano (Cboe CA: VRNO) announced the opening of Zen Leaf Charleston, its sixth West Virginia dispensary and the company’s 159th location nationwide. The store at 117 Summers Street will open Friday, January 2nd and is open Monday–Saturday 10:00 a.m.–7:00 p.m. and Sunday 10:00 a.m.–5:00 p.m.
Verano reports over 35,000 approved medical cannabis patients in West Virginia and operates a 40,000 sq ft cultivation and processing facility in Beaver. Company operations span 13 states with 159 dispensaries, 15 cultivation and processing facilities and more than 1 million sq ft of cultivation capacity.
Verano (Cboe CA: VRNO / OTCQX: VRNO) celebrated the Dec. 18, 2025 Executive Order directing DOJ to reschedule cannabis from Schedule I to Schedule III, calling it a historic policy shift. Verano highlighted potential benefits including banking, tax, medical research reforms and the opportunity to list on a U.S. exchange. The company said its operations span 13 states, with 158 dispensaries under Zen Leaf and MÜV and 15 cultivation/processing facilities totaling more than 1.1 million sq ft of capacity.
CEO George Archos described rescheduling as enabling patient access, jobs, and economic growth while noting forward-looking risks remain.
Verano (VRNO) announced on December 2, 2025 that the Texas Department of Public Safety awarded the company a conditional Dispensing Organization License under Phase 1 of the state’s Compassionate Use Program expansion. Subject to final state approval after further due diligence, the license permits Verano to cultivate, process and dispense medical cannabis across Texas.
Verano said it currently operates in 13 states with 158 Zen Leaf and MÜV dispensaries, 15 cultivation and processing facilities, and over 1.1 million sq ft of cultivation capacity, and plans to offer Texas-grown medical products if final approvals are granted.
FAQ
What is the current stock price of Verano Hldgs (VRNO)?
